Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill

Che Wen-jun; He Xiao-zhou; Jiang Jian-pin; Cai Wen-yuan; Xie Si-jie

doi:10.1007/BF02835794

Your Location：

Home >

Browse articles >

Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill

Updated：2021-08-27

- Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill
- Chinese Journal of Integrative Medicine Vol. 11, Issue 4, Pages: 300-302(2005)
- Affiliations：
  
  The First Hospital of Changzhou City, the 3rd Affiliated Hospital of Suzhou University,Jiangsu
- Author bio：
- Funds：
- DOI：10.1007/BF02835794
  CLC：
- Published：2005，
Scan for full text
Wen-jun, C., Xiao-zhou, H., Jian-pin, J. et al. Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill., Chin. J. Integr. Med. 11, 300–302 (2005). https://doi.org/10.1007/BF02835794

Che Wen-jun, He Xiao-zhou, Jiang Jian-pin, et al. Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill. [J]. Chinese Journal of Integrative Medicine 11(4):300-302(2005)
Wen-jun, C., Xiao-zhou, H., Jian-pin, J. et al. Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill., Chin. J. Integr. Med. 11, 300–302 (2005). https://doi.org/10.1007/BF02835794 DOI：

Che Wen-jun, He Xiao-zhou, Jiang Jian-pin, et al. Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill. [J]. Chinese Journal of Integrative Medicine 11(4):300-302(2005) DOI： 10.1007/BF02835794.

摘要

Objective: To observe the efficacy and safety of Jingui Shengqi Pill (JSP) in treating partial androgen deficiency in aging males (PADAM)

and to explore the new approach in improving the quality of life in PADAM patients.Methods: Forty patients with PADAM were treated with JSP

the efficacy was evaluated with international index of erectile function (IIEF) scoring

PADAM questionnaire scoring

hormone

prostatic specific antigen (PSA)

etc.

and the data before treatment were compared with those after treatment in the same group.Results: After 3 months of treatment

PADAM scoring and IIEF scoring were all significantly improved. Symptoms regarding physical ability

vasomotion

and psychical and mental condition all got improved more markedly than symptoms regarding sexual hypofunction. The serum level of testosterone was 3.85 ±0.36 before treatment and 5.02 ±0.83 after treatmnet (P<0.05); luteinizing hormone of 7.33 ±2.14 and 4.84 ±1.43 (P<0.01)

follicule-stimulating hormone of 10.22 ±4.48 and 6.47 ± 3.28 (P<0.01)

respectively. The level of PSA failed to change significantly (1.94 ±0.55 and 2.06 ± 0. 47

P>0.05)Conclusion: JSP is effective and safe in treating PADAM

the mechanism of it is different from supplementing extrinsic androgen. It may have produced the effect by means of favorably regulating the condition of sex hormone to improve the balance of pituitary-sex gland axis

so it has more extensive clinical application.

Abstract

Objective: To observe the efficacy and safety of Jingui Shengqi Pill (JSP) in treating partial androgen deficiency in aging males (PADAM)

and to explore the new approach in improving the quality of life in PADAM patients.Methods: Forty patients with PADAM were treated with JSP

the efficacy was evaluated with international index of erectile function (IIEF) scoring

PADAM questionnaire scoring

hormone

prostatic specific antigen (PSA)

etc.

and the data before treatment were compared with those after treatment in the same group.Results: After 3 months of treatment

PADAM scoring and IIEF scoring were all significantly improved. Symptoms regarding physical ability

vasomotion

follicule-stimulating hormone of 10.22 ±4.48 and 6.47 ± 3.28 (P<0.01)

respectively. The level of PSA failed to change significantly (1.94 ±0.55 and 2.06 ± 0. 47

P>0.05)Conclusion: JSP is effective and safe in treating PADAM

so it has more extensive clinical application.

关键词

Jingui Shenqi Pillpartial androgen deficiency in aging malehormone

Keywords

Jingui Shenqi Pillpartial androgen deficiency in aging malehormone

references

Gooren LJG. The age-related decline of androgen levels in men: clinically significant? Br J Urol 1996; 78: 763–768.

Li JY. Partial androgen deficiency syndrome in aging males. J Reprod Med 2000;9(3): 182–186.

Wang YF. Direction of andrology —From disease dominance to health dominance. Chin J Androl 2003; 9 (3): 163–165.

Chinese Association of Andrology. Basic principles for diagnosis, treatment and monitoring of partial androgen deficiency syndrome of middle-elder aged males in China. Chin J Androl 2002; 17(1): 66–68.

Yang RM. Clinical observation on 106 patients with partial androgen deficiency syndrome of middle-elder aged males treated with androgen supplement therapy. Geriatr & Health Care 2001;7(4): 212–213.

Li JY, Zhu JC, Dou JT, et al. Preliminary study on testosterone supplementing in treatment of partial androgen deficiency syndrome in middle-elder aged males. Geriatr & Health Care 2001;7(4): 209–211.

Xin ZC. Progress on study of senile male androgen deficiency syndrome and testosterone supplementing therapy. Chin J Androl 2003;22(6): 333–334.

Gong B, Mo QZ, Ma J, et al. Study on mechanism of Chinese herbal medicine for tonifying Shen in retarding aging of cerebral function in old mice. Chin J Gerontol 1996;6(2): 170–172.

Wang XL, Li YC, Hou YC. Effect of Jingui Shenqi Pill in antagonizing free radical and inducing cell apoptosis. J Fourth Milit Med Univ 2000; 21 (10): 1209.

Yu XE. New application of Jinkui Shenqi Pill. J Anhui Tradit Chin Med 1999; 18(6): 50.

Chen QP, Guo LY. Experimental study on effects of Jingui Shenqi Pill and Liuwei Dihuang Pill on sex hormone in mice. Chin Pharm 1999; 10(6): 255.

Zhang JW, Lu ZL. Effect of Jingui Shenqi Pill on the level of sex hormones in Jingui Shenqi Pill Syndrome patients. Liaoning J Coll Tradit Chin Med 2002; 29 (5): 251–252.

FULL TEXT LINK

More>

Views

366

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰